The information on this page about projects and other funding data may not be exhaustive for reasons of confidentiality and intellectual and industrial property protection. If you need more complete information, please contact the institution.

53 funding €10,083,219.00

data available since 2018
filter_list

2025

  1. Phase 2 trial of intratumoral DNX-2401 in children and young

    €1,000,000.00

  2. Tamáriz, Luis - AECC Clínico Junior 2025

    €154,000.00

  3. Técnicas de perfusión por resonancia magnética para el control intraoperatorio de la resección en la cirugía de tumores cerebrales (iRMI-GLIOMA)

    €150,000.00

  4. Movilidad AECC Iratxe Ugarte

    €5,000.00

2024

  1. Neoadjuvant-adjuvant immunotherapy and cancer vaccines to improve survival in hepatocellular carcinoma

    €600,000.00

  2. Small cell lung cancer: from biology networks to tailored therapy - Small cell lung cancer (SOSCLC)

    €45,500.00

  3. Rational to modulate the Microbiome-induced Endoplasmic Reticulum stress as tool to avoid the immune evasion in Hepatocellular Carcinoma (RETO)

    €42,162.00

  4. Estudio de los mecanismos de resistencia y de infección en paciente con mieloma en recaída y refractario en tratamiento con anticuerpos biespecíficos.

    €240,000.00

  5. CARACTERIZACIÓN DE LA HETEROGENEIDAD MOLECULAR Y TRANSCRIPCIONAL DE LOS LINFOMAS DEL CENTRO GERMINAL: LINFOMA DE CÉLULAS GRANDES B Y LINFOMA FOLICULAR

    €140,000.00

  6. Epigenetic landscape of immune resistance in pancreatic cancer

    €54,705.00

  7. Small cell lung cancer: from biology networks to tailored therapy - Small cell lung cancer (SOSCLC)

    €35,000.00

2023

  1. Rational to modulate the Microbiome and the Microbiome-induced Endoplasmic Reticulum stress as tool to avoid the immune evasion in Hepatocellular Carcinoma (RETO)

    €309,592.00

  2. First-in-human, open-label, prospective, non-randomized clinical trial to evaluate the safety of ARI-HER2 (HER2BBz CAR-T cells) in subjects with relapse or refractory HER2-positive metastatic breast cancer.

    €22,000.00

  3. AECC POSTD235059RUIZ

    €125,000.00

  4. Profundización en la vía del Enpp1: efectos autónomos e implicaciones para la radioterapia del cáncer de mama triple negativo

    €240,000.00

  5. Hijacking stroma antigens for CAR-T cell immunotherapy of PDAC

    €100,000.00

  6. Boosting abscopal effect and minimizing locoregional failure by blockade of IL6/STAT3/SMG1 axis in onco-radiotherapy

    €150,000.00

  7. Hijacking stroma antigens for CAR-T cell immunotherapy of PDAC

    €110,000.00

  8. Epigenetic landscape of immune resistance in pancreatic cancer.

    €300,000.00

  9. PREDOC AECC 2023 ENEKO GARATE

    €21,815.00

The information on this page about projects and other funding data may not be exhaustive for reasons of confidentiality and intellectual and industrial property protection. If you need more complete information, please contact the institution.